Back to Search
PRATEEK BALI, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1881438240Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
PCR-based methods for the detection of L1014 kdr mutation in Anopheles culicifacies sensu lato.
PMID 19594947·Malar J·2009
7-preclinical
Alleles -308A and -1031C in the TNF-alpha gene promoter do not increase the risk but associated with circulating levels of TNF-alpha and clinical features of vivax malaria in Indian patients.
PMID 17996942·Mol Immunol·2008
8-other
Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-alpha levels and transcriptional activity: a result of hyperacetylation and inhibition of chaperone function of heat shock protein 90.
PMID 17699868·Clin Cancer Res·2007
8-other
Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cells.
PMID 17020995·Clin Cancer Res·2006
7-preclinical
Combined effects of novel tyrosine kinase inhibitor AMN107 and histone deacetylase inhibitor LBH589 against Bcr-Abl-expressing human leukemia cells.
PMID 16537804·Blood·2006
7-preclinical
Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.
PMID 15937340·J Biol Chem·2005
8-other
Germ cell-specific localization of immunoreactive riboflavin carrier protein in the male golden hamster: appearance during spermatogenesis and role in sperm function.
PMID 15855621·Reproduction·2005
7-preclinical
Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3.
PMID 15514006·Blood·2005
8-other
Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin.
PMID 16288046·Cancer Res·2005
8-other
Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824.
PMID 16170022·Mol Cancer Ther·2005
4-observational
Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2.
PMID 16144943·Clin Cancer Res·2005
8-other
polyethylene glycol-conjugated adenosine deaminase (ADA) therapy provides temporary immune reconstitution to a child with delayed-onset ADA deficiency.
PMID 16002636·Clin Diagn Lab Immunol·2005
5-case
Mechanistic role of heat shock protein 70 in Bcr-Abl-mediated resistance to apoptosis in human acute leukemia cells.
PMID 15388581·Blood·2005
8-other
A new work placement model for unemployed methadone maintenance patients.
PMID 15603003·Subst Use Misuse·2004
6-review
Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3.
PMID 15297399·Clin Cancer Res·2004
8-other
Cotreatment with 17-allylamino-demethoxygeldanamycin and FLT-3 kinase inhibitor PKC412 is highly effective against human acute myelogenous leukemia cells with mutant FLT-3.
PMID 15150124·Cancer Res·2004
8-other
Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells.
PMID 15059915·Cancer Res·2004
8-other
Efficacy of the customized employment supports (CES) model of vocational rehabilitation for unemployed methadone patients: preliminary results.
PMID 15603004·Subst Use Misuse·2004
3-trial
Convergent validity of the ASAM Patient Placement Criteria using a standardized computer algorithm.
PMID 15991590·J Addict Dis·2003
4-observational
Arsenic trioxide inhibits translation of mRNA of bcr-abl, resulting in attenuation of Bcr-Abl levels and apoptosis of human leukemia cells.
PMID 14633726·Cancer Res·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8900 VAN WYCK EXPY
RICHMOND HILL, NY 11418 - Phone
- (718) 206-6000
Quick Facts
- NPI
- 1881438240
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile